The importance is efficacy of this combination in enhancing anti-tumor activity of CP in vivo, so that the combination of CP and shikonin effectively suppresses tumor growth in colon cancer (HCT116 xenograft tumor) [227]. The gene discussed is CP; the disease is colonic neoplasm.